282 related articles for article (PubMed ID: 27987042)
41. IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages.
Assani K; Tazi MF; Amer AO; Kopp BT
PLoS One; 2014; 9(5):e96681. PubMed ID: 24798083
[TBL] [Abstract][Full Text] [Related]
42. The Burkholderia cenocepacia peptidoglycan-associated lipoprotein is involved in epithelial cell attachment and elicitation of inflammation.
Dennehy R; Romano M; Ruggiero A; Mohamed YF; Dignam SL; Mujica Troncoso C; Callaghan M; Valvano MA; Berisio R; McClean S
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27886433
[TBL] [Abstract][Full Text] [Related]
43. Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.
Zlosnik JE; Zhou G; Brant R; Henry DA; Hird TJ; Mahenthiralingam E; Chilvers MA; Wilcox P; Speert DP
Ann Am Thorac Soc; 2015 Jan; 12(1):70-8. PubMed ID: 25474359
[TBL] [Abstract][Full Text] [Related]
44. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
Silva IN; Ferreira AS; Becker JD; Zlosnik JEA; Speert DP; He J; Mil-Homens D; Moreira LM
Microbiology (Reading); 2011 Nov; 157(Pt 11):3124-3137. PubMed ID: 21835880
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic diversity and genotypic flexibility of
Lee AH; Flibotte S; Sinha S; Paiero A; Ehrlich RL; Balashov S; Ehrlich GD; Zlosnik JE; Mell JC; Nislow C
Genome Res; 2017 Apr; 27(4):650-662. PubMed ID: 28325850
[TBL] [Abstract][Full Text] [Related]
46. Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice.
Chattoraj SS; Murthy R; Ganesan S; Goldberg JB; Zhao Y; Hershenson MB; Sajjan US
Infect Immun; 2010 Mar; 78(3):984-93. PubMed ID: 20048042
[TBL] [Abstract][Full Text] [Related]
47.
Ji Y; Bolhuis A; Watson ML
J Med Microbiol; 2019 Dec; 68(12):1813-1822. PubMed ID: 31674896
[No Abstract] [Full Text] [Related]
48. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
[TBL] [Abstract][Full Text] [Related]
49. Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients.
Dedeckova K; Kalferstova L; Strnad H; Vavrova J; Drevinek P
J Cyst Fibros; 2013 Sep; 12(5):475-81. PubMed ID: 23317764
[TBL] [Abstract][Full Text] [Related]
50. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
51. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
52. Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules.
Rosales-Reyes R; Garza-Villafuerte P; Vences-Vences D; Aubert DF; Aca-Teutle R; Ortiz-Navarrete VF; Bonifaz LC; Carrero-Sánchez JC; Olivos-García A; Valvano MA; Santos-Preciado JI
Emerg Microbes Infect; 2020 Dec; 9(1):2000-2012. PubMed ID: 32873215
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults.
Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS
J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892
[TBL] [Abstract][Full Text] [Related]
54. Insights into the genome diversity and virulence of two clinical isolates of Burkholderia cenocepacia.
Salloum T; Nassour E; Araj GF; Abboud E; Tokajian S
J Med Microbiol; 2018 Aug; 67(8):1157-1167. PubMed ID: 29897328
[TBL] [Abstract][Full Text] [Related]
55. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
[TBL] [Abstract][Full Text] [Related]
56. Mutation of
Moustafa DA; Wu L; Ivey M; Fankhauser SC; Goldberg JB
Microbiol Spectr; 2024 Jul; 12(7):e0041024. PubMed ID: 38809005
[TBL] [Abstract][Full Text] [Related]
57. Analysis of human bronchial epithelial cell proinflammatory response to Burkholderia cenocepacia infection: inability to secrete il-1β.
Gillette DD; Shah PA; Cremer T; Gavrilin MA; Besecker BY; Sarkar A; Knoell DL; Cormet-Boyaka E; Wewers MD; Butchar JP; Tridandapani S
J Biol Chem; 2013 Feb; 288(6):3691-5. PubMed ID: 23269671
[TBL] [Abstract][Full Text] [Related]
58. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.
Dallal MM; Telefian CF; Hajia M; Kalantar E; Dehkharghani AR; Forushani AR; Khanbabaei Q; Mobarhan M; Farzami MR
J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029
[TBL] [Abstract][Full Text] [Related]
59. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
60. A decade of Burkholderia cenocepacia virulence determinant research.
Loutet SA; Valvano MA
Infect Immun; 2010 Oct; 78(10):4088-100. PubMed ID: 20643851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
